CLONAL HEMATOPOIESIS

Clinical trials for CLONAL HEMATOPOIESIS explained in plain language.

Never miss a new study

Get alerted when new CLONAL HEMATOPOIESIS trials appear

Sign up with your email to follow new studies for CLONAL HEMATOPOIESIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 1

Could a gentle pill stop blood cancer before it starts?

Disease control Not yet recruiting

This study tests a low-dose oral drug (decitabine with tetrahydrouridine) in 80 adults aged 60–85 who have a high-risk blood condition called CCUS, which often leads to blood cancer. The drug aims to reduce harmful mutations in blood cells and restore normal blood production with…

Matched conditions: CLONAL HEMATOPOIESIS

Phase: PHASE2 • Sponsor: Clinical Hub for Interventional Research (CHOIR) • Aim: Disease control

Last updated Jun 27, 2026 09:08 UTC

CLONAL HEMATOPOIESIS

Get alerted when new CLONAL HEMATOPOIESIS trials appear

Could a gentle pill stop blood cancer before it starts?